SteadyMed Ltd. (NASDAQ:STDY) is scheduled to be releasing its earnings data before the market opens on Monday, August 14th. Analysts expect SteadyMed to post earnings of ($0.32) per share for the quarter.

SteadyMed Ltd. (STDY) opened at 6.25 on Monday. The company’s 50 day moving average is $6.49 and its 200-day moving average is $5.43. The firm’s market cap is $157.32 million. SteadyMed Ltd. has a 1-year low of $2.25 and a 1-year high of $9.70.

Separately, Zacks Investment Research lowered shares of SteadyMed from a “hold” rating to a “sell” rating in a research report on Tuesday, June 6th.

ILLEGAL ACTIVITY NOTICE: “SteadyMed Ltd. (STDY) to Release Earnings on Monday” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/07/steadymed-ltd-stdy-to-release-earnings-on-monday.html.

About SteadyMed

SteadyMed Ltd. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of various therapeutic product candidates. Its primary focus is to obtain approval in the United States for the sale of Trevyent for the treatment of pulmonary arterial hypertension (PAH).

Earnings History for SteadyMed (NASDAQ:STDY)

Receive News & Ratings for SteadyMed Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SteadyMed Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.